Cheminformatics

HEDGEHOG: Hierarchical Evaluation of Drug Generators Through Rigorous Filtration

Daria A. Ryabchenko, Pavel Gurevich, Shamil Kadyrov, Daria Frolova, Kseniia Fedisheva, Sergei A. Nikolenko, Alexander Shapeev, Marina A. Pak

Featured August 7, 2026

Original Paper

AI-generated analysis — This is SciGrove's AI interpretation of the paper, not peer-reviewed content. Always refer to the original paper.

Simply

Most new drug molecules created by AI look good at first, but a new six-step test called HEDGEHOG shows that almost all of them fail basic checks for being safe, buildable, and actually working.

In depth

The paper introduces HEDGEHOG, a novel six-stage filtration benchmark designed to rigorously evaluate generative molecular models by mimicking industrial hit identification workflows. This benchmark exposes a critical limitation: molecules appearing acceptable under isolated criteria rarely satisfy a comprehensive set of medicinal chemistry, synthesis, docking, and 3D pose filters simultaneously, leading to a very low end-to-end survival rate for generated compounds.

Key Takeaways

1
Current molecular generators produce compounds that largely fail a multi-stage computational triage, with only 0.65% of initial molecules surviving all six filters in the HEDGEHOG benchmark.
2
The hierarchical filtration approach, moving from inexpensive target-agnostic checks to costly target-aware evaluations, efficiently identifies chemically implausible molecules early, reducing computational waste.
3
The HEDGEHOG benchmark provides a diagnostic tool to identify specific failure modes of generative models at different stages, highlighting the need for models that balance multiple drug-likeness criteria simultaneously.

Conceptual Flow

HIGH LEVEL

Methodology: The Six-Stage Filtration

The new method checks new molecules through six steps, like a funnel, to find only the best ones for making medicine.

New Molecules

Filter Step by Step

Best Candidates

Results: Very Few Molecules Survive

Even though many molecules are made, very, very few pass all the strict tests, showing that making good drugs is still very hard.

Many Molecules Start

Most Fail Tests

Few Molecules Remain

This breakdown was generated by SciGrove. Get the same analysis — intuition, storyboard, peer review, a runnable prototype and a glossary — on any paper you upload or paste a DOI for.